Cargando…
Acarbose Treatment and the Risk of Cardiovascular Disease in Type 2 Diabetic Patients: A Nationwide Seven-Year Follow-Up Study
Objective. To investigate the potential benefits of acarbose treatment on cardiovascular disease (CVD) in patients with type 2 diabetes by using nationwide insurance claim dataset. Research Design and Methods. Among 644,792 newly diagnosed type 2 diabetic patients without preexisting CVD in a nation...
Autores principales: | Chen, Jui-Ming, Chang, Cheng-Wei, Lin, Ying-Chieh, Horng, Jorng-Tzong, Sheu, Wayne H.-H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147291/ https://www.ncbi.nlm.nih.gov/pubmed/25197673 http://dx.doi.org/10.1155/2014/812628 |
Ejemplares similares
-
Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan
por: Lin, Ying-Chieh, et al.
Publicado: (2020) -
Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer's Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan
por: Chang, Cheng-Wei, et al.
Publicado: (2016) -
Effects of Statins on Incident Dementia in Patients with Type 2 DM: A Population-Based Retrospective Cohort Study in Taiwan
por: Chen, Jui-Ming, et al.
Publicado: (2014) -
On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014) -
Diabetic Patients with Severe Sepsis Admitted to Intensive Care Unit Do Not Fare Worse than Non-Diabetic Patients: A Nationwide Population-Based Cohort Study
por: Chang, Cheng-Wei, et al.
Publicado: (2012)